Natera co-founder sells over $2.8 million in company stock

In a recent transaction, Sheena Jonathan, Co-Founder of Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, sold a significant amount of company stock. The sales, which took place on September 18, 2024, totaled over $2.8 million. The transactions …

CouponFollow Extension

$2
OFF

Natera Co-founder Sells Over $2.8 Million In Company Stock

1 week from now

investing.com

$2
OFF

Natera Co-founder Sells Over $2.8 Million In Company Stock

1 week from now

In a recent transaction, Sheena Jonathan, Co-Founder of Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, sold a significant amount of company stock. …

investing.com

$28
OFF

Natera Cofounder Sells Over $28 Million In Company...

1 week from now

Sep 23, 2024 6:57 AM - Parth Sanghvi. In a significant move, Natera, a leading genetic testing and diagnostics company, saw its cofounder sell over $28 million worth of company stock, …

financialmodelingprep.com

$2
OFF

Natera Co-founder Sells Over $2.8 Million In Company Stock

1 week from now

Sep 21, 2024 · Natera co-founder sells over $2.8 million in company stock

investing.com

$280
OFF

Natera Co-founder Sheena Jonathan Sells Over $280k In Company …

1 week from now

May 10, 2024 · In a recent transaction, Sheena Jonathan, co-founder of Natera, Inc. (NASDAQ: NTRA), a leader in medical laboratory services, sold a total of $283,794 worth of company …

investing.com

$5.62
OFF

Natera Co-founder Sheena Jonathan Sells $5.62 Million In Stock

1 week from now

NTRA. -. Sheena Jonathan, the co-founder and director of Natera, Inc. (NASDAQ:NTRA), has sold a significant portion of her holdings in the company. According to a recent filing, Jonathan …

investing.com

$5
OFF

Natera Executives Sell Shares Worth Over $5.9 Million

1 week from now

1 day ago · Natera Director Marcus Gail Boxer sold 2,212 shares of common stock on November 14, 2024, with transactions ranging in price from $156.754 to $162.04, reported as weighted …

tradingview.com

$5.62
OFF

Natera Co-founder Sheena Jonathan Sells $5.62 Million In Stock

1 week from now

1 day ago · Sheena Jonathan, the co-founder and director of Natera, Inc. (NASDAQ:NTRA), has sold a significant portion of her holdings in the company. According to a recent filing, Jonathan …

investing.com

$28
OFF

Natera Cofounder Sells Over $28 Million In Company Stock: …

1 week from now

September 23, 2024 Financial Modeling Prep. In a significant move, Natera, a leading genetic testing and diagnostics company, saw its cofounder sell over $28 million worth of company …

cbonds.com

$119
OFF

Natera (Nasdaq:NTRA) - Stock Price, News & Analysis - Simply …

1 week from now

2 days ago · Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$119. Natera, Inc. Provides Earnings Guidance for the Year 2024. …

simplywall.st

$280
OFF

Natera Co-founder Sheena Jonathan Sells Over $280k In Company …

1 week from now

May 11, 2024 · In a recent transaction, Sheena Jonathan, co-founder of Natera, Inc. (NASDAQ:NTRA), a leader in medical laboratory services, sold a total of $283,794 worth of …

investing.com

$2
OFF

Natera Co-founder Sells Over $2.8 Million In Company Stock

1 week from now

Sep 21, 2024 · In a latest transaction, Sheena Jonathan, Co-Founding father of Natera, Inc. (NASDAQ:), a pacesetter in personalised genetic testing and diagnostics, Natera co-founder …

fundscrafter.com

$2
OFF

Natera Co-founder Sells Over $2.8 Million In Company Stock By …

1 week from now

In a recent transaction, Sheena Jonathan, Co-Founder of Natera, Inc. (NASDAQ:), a leader in personalized genetic testing and diagnostics, sold a significant amount of company stock. The …

onswm.com

84%
OFF

Natera Co-Founder Sells Over $2.8 Million In Company Stock

1 week from now

In a recent development, Sheena Jonathan, Co-Founder of Natera, Inc., executed a substantial sale of company stock amounting to over $2.8 million on September AAPL $225.77 1.84%

marketbeatnow.com

$108
OFF

Natera Co-founder Sells Over $108k In Company Stock

1 week from now

In a recent transaction, Sheena Jonathan, co-founder of Natera, Inc. (NASDAQ: NTRA), a leader in medical laboratory services, sold a number of shares in the company.The sales took place …

investing.com

$2
OFF

Natera Co-founder Sells Over $2.8 Million In Company Stock By …

1 week from now

In a recent transaction, Sheena Jonathan, Co-Founder of Natera, Inc. (NASDAQ:), a leader in personalized genetic testing and diagnostics, sold Natera co-founder sells over $2.8 million in …

theadvisertimes.com

FAQs about Natera co-founder sells over $2.8 million in company stock Coupon?

How did Natera's stock perform on Tuesday?

On Tuesday, Natera's stock (Nasdaq: NTRA) closed regular trading up 13 cents, or less than 1%,\ to $35.42 a piece. There was no mention of Natera's stock price being affected by their own layoffs in the provided passage. The passage only mentions Synthego's layoffs and their previous funding round. ...

Why did Natera hold an investor call on March 10th?

Natera held an investor call on March 10th at 7am, hosted by Steve Chapman, Natera’s CEO. The company opened its press release by stating that 'an attempt to make a quick profit' was being made by Hindenburg Research, who are currently under criminal investigation by the Department of Justice for illegal trading tactics. ...

How did Natera collect from the insurance company?

Natera was able to get paid from both the insurer and the expectant mother by unbundling the test. They failed to share the second page of the invoice, hiding their practice of billing patients for what is essentially an un-reimbursable cost under most insurance plans. ...

When did Natera go public and at what share price?

Natera went public on July 1, 2015, at $18 per share. The company currently has a market cap of $5.2 billion and is led by CEO Steve Chapman. ...

Why did Natera pay $11 million?

Natera paid $11 million in 2018 to settle Department of Justice fraud allegations. The allegations were related to improper sales and billing of Panorama, its key NIPT test, between 2013 and 2016. In late 2017, payors imposed “prior authorization” requirements for Natera’s tests to curb excessive billing. ...

Does Natera (NTRA) have a follow-on equity offering?

Natera, Inc. has completed a Follow-on Equity Offering in the amount of $250.25 million. Natera, Inc. Announces Data from the ProActive Study that Supports Prospera™? Kidney as an Early Indicator of Transplant Rejection Health Check: How Prudently Does Natera (NASDAQ:NTRA) Use Debt? ...